Matthijs Kruizinga
Matthijs Kruizinga
Juliana Children's Hospital
Verified email at
Cited by
Cited by
The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature
MD Kruizinga, D Peeters, M van Veen, M van Houten, J Wieringa, ...
European journal of pediatrics 180, 2271-2279, 2021
Risk factors, treatment, and immune dysregulation in autoimmune cytopenia after allogeneic hematopoietic stem cell transplantation in pediatric patients
MD Kruizinga, MJD van Tol, V Bekker, T Netelenbos, FJ Smiers, ...
Biology of Blood and Marrow Transplantation 24 (4), 772-778, 2018
Development of novel, value-based, digital endpoints for clinical trials: a structured approach toward fit-for-purpose validation
MD Kruizinga, FE Stuurman, V Exadaktylos, RJ Doll, DT Stephenson, ...
Pharmacological Reviews 72 (4), 899-909, 2020
Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosis
MD Kruizinga, E Essers, FE Stuurman, A Zhuparris, N van Eik, ...
Pediatric Pulmonology 55 (9), 2463-2470, 2020
The future of clinical trial design: the transition from hard endpoints to value-based endpoints
MD Kruizinga, FE Stuurman, GJ Groeneveld, AF Cohen
Concepts and Principles of Pharmacology: 100 Years of the Handbook of …, 2019
Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for …
MD Kruizinga, WAJ Birkhoff, MJ van Esdonk, NB Klarenbeek, ...
British Journal of Clinical Pharmacology 86 (1), 175-181, 2020
Finding suitable clinical endpoints for a potential treatment of a rare genetic disease: the case of ARID1B
MD Kruizinga, RGJA Zuiker, E Sali, ML de Kam, RJ Doll, GJ Groeneveld, ...
Neurotherapeutics 17, 1300-1310, 2020
Towards remote monitoring in pediatric care and clinical trials—Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity …
MD Kruizinga, N Heide, A Moll, A Zhuparris, Y Yavuz, ML Kam, ...
PloS one 16 (1), e0244877, 2021
The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients
MD Kruizinga, D Bresters, FJ Smiers, AC Lankester, RGM Bredius
Pediatric Blood & Cancer 64 (8), e26453, 2017
Effect of intellivent-asv versus conventional ventilation on ventilation intensity in patients with covid-19 ards—an observational study
LA Buiteman-Kruizinga, HE Mkadmi, A Serpa Neto, MD Kruizinga, ...
Journal of Clinical Medicine 10 (22), 5409, 2021
Development and technical validation of a smartphone-based cry detection algorithm
A ZhuParris, MD Kruizinga, M Gent, E Dessing, V Exadaktylos, RJ Doll, ...
Frontiers in pediatrics 9, 651356, 2021
Adverse effect of lockdowns during the COVID-19 pandemic: increased incidence of pediatric crisis admissions due to eating disorders and adolescent intoxications
JM Kersten, M van Veen, MA van Houten, J Wieringa, JG Noordzij, ...
European Journal of Pediatrics 182 (3), 1137-1142, 2023
Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study
A Samb, M Kruizinga, Y Tallahi, M van Esdonk, W van Heel, G Driessen, ...
British Journal of Clinical Pharmacology 88 (4), 1845-1855, 2022
Development and technical validation of a smartphone‐based pediatric cough detection algorithm
MD Kruizinga, A Zhuparris, E Dessing, FJ Krol, AJ Sprij, RJ Doll, ...
Pediatric Pulmonology 57 (3), 761-767, 2022
Postdischarge recovery after acute pediatric lung disease can be quantified with digital biomarkers
MD Kruizinga, A Moll, A Zhuparris, D Ziagkos, FE Stuurman, M Nuijsink, ...
Respiration 100 (10), 979-988, 2021
Effect of lockdowns on the epidemiology of pediatric respiratory disease—A retrospective analysis of the 2021 summer epidemic
MD Kruizinga, JG Noordzij, MA van Houten, J Wieringa, ...
Pediatric Pulmonology 58 (4), 1229-1236, 2023
Theoretical performance of nonlinear mixed-effect models incorporating saliva as an alternative sampling matrix for therapeutic drug monitoring in pediatrics: a simulation study
MD Kruizinga, FE Stuurman, GJA Driessen, AF Cohen, KR Bergmann, ...
Therapeutic Drug Monitoring 43 (4), 546-554, 2021
Clinical validation of digital biomarkers for paediatric patients with asthma and cystic fibrosis: potential for clinical trials and clinical care
MD Kruizinga, E Essers, FE Stuurman, Y Yavuz, ML de Kam, A Zhuparris, ...
European Respiratory Journal 59 (6), 2022
Mitochondrial function, grip strength, and activity are related to recovery of mobility after a total knee arthroplasty
MPJ van Diemen, D Ziagkos, MD Kruizinga, MR Bénard, P Lambrechtse, ...
Clinical and Translational Science 16 (2), 224-235, 2023
Objective home-monitoring of physical activity, cardiovascular parameters, and sleep in pediatric obesity
JM Knijff, ECAM Houdijk, D van der Kaay, Y van Berkel, L Filippini, ...
Digital biomarkers 6 (1), 19-30, 2022
The system can't perform the operation now. Try again later.
Articles 1–20